US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Bioxyne Ltd (BXN) 銘柄情報

Bioxyne Ltd (BXN)

0.93

0.00

( 0.00% )

更新日時： 09:00:00

Bioxyne Ltd (BXN) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.93

( - )

買値

0.00

売値

0.00

出来高

0.00

平均取引量 (3 か月)

AUD 422,389

財務取引量

-

0.00 日の範囲 0.00

0.0335 52 週間の範囲 0.965

時価総額

企業価値

213.943M

前日終値

0.93

始値

-

時刻

最終取引時間

-

VWAP

-

歳入

47.95M

純利益

8.97M

発行済株式数

229,977,671

浮動株比率 (%)

32.62%

機関投資家保有比率 (%)

-

配当利回り

PER

23.69

株価売上高倍率 (PSR)

4.51

1 株当たり利益 (EPS)

0.04

ベータ

0.65

BLS Pharmaceuticals Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan. The company offers medical cannabis, MDMA, psilocybin, prescription medicines,... BLS Pharmaceuticals Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan. The company offers medical cannabis, MDMA, psilocybin, prescription medicines, probiotics, NADs, and consumer health products under the Dr Watson and PCC brands. It also provides pharmaceutical manufacturing, wholesale, distribution, import, export, and contract drug manufacturing services for investigational and psychotropic medicines. The company caters to licensed clinics, pharmacies, wholesale distributors, cultivators, active pharmaceutical ingredient manufacturers, and pharmaceutical brand sponsors. The company was formerly known as Bioxyne Limited and changed its name to BLS Pharmaceuticals Limited in June 2026. BLS Pharmaceuticals Limited was incorporated in 1998 and is headquartered in Sydney, Australia. 詳細を表示

セクター

Consumer Staples

業界

Consumer Products - Foods

ウェブサイト

blspharma.com

本社

Sydney, Australia

設立

1998

Bioxyne Ltd is listed in the Consumer Staples sector of the オーストラリア証券取引所 with ticker BXN. The last closing price for Bioxyne was AUD0.93. Over the last year, Bioxyne shares have traded in a share price range of AUD 0.0335 to AUD 0.965.

Bioxyne currently has 229,977,671 shares in issue. The market capitalisation of Bioxyne is AUD213.88 million. Bioxyne has a price to earnings ratio (PE ratio) of 23.69.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.93	0.965	0.9	207225	0.93170096	DE
4	0.844	981.395348837	0.086	0.965	0.082	3664712	0.10515118	DE
12	0.862	1267.64705882	0.068	0.965	0.055	4434762	0.08210393	DE
26	0.89	2225	0.04	0.965	0.036	4011474	0.06646548	DE
52	0.89	2225	0.04	0.965	0.0335	3722353	0.05556717	DE
156	0.914	5712.5	0.016	0.965	0.004	2683340	0.03884939	DE
260	0.9	3000	0.03	0.965	0.004	1882136	0.03821505	DE

BXN - Frequently Asked Questions (FAQ)

What is the current Bioxyne Ltd share price?

The current share price of Bioxyne Ltd is AUD 0.93

How many Bioxyne Ltd shares are in issue?

Bioxyne Ltd has 229,977,671 shares in issue

What is the market cap of Bioxyne Ltd?

The market capitalisation of Bioxyne Ltd is AUD 213.88M

What is the 1 year trading range for Bioxyne Ltd share price?

Bioxyne Ltd has traded in the range of AUD 0.0335 to AUD 0.965 during the past year

What is the PE ratio of Bioxyne Ltd?

The price to earnings ratio of Bioxyne Ltd is 23.69

What is the cash to sales ratio of Bioxyne Ltd?

The cash to sales ratio of Bioxyne Ltd is 4.51

What is the registered address of Bioxyne Ltd?

The registered address for Bioxyne Ltd is Level 5, Sydney, New South Wales, 2000

What is the Bioxyne Ltd website address?

The website address for Bioxyne Ltd is blspharma.com

Which industry sector does Bioxyne Ltd operate in?

Bioxyne Ltd operates in the Consumer Products - Foods sector

GoldenCyclops48

GoldenCyclops48 3分前

How do you know so much or are you like so smart you don't have a life. You sure spend a lot of intellectual energy here. Boring...

MrMontag

MrMontag 4分前

Trump isn't saying anything about this or making any calls on this. His hands are plenty full. Don't be naive.

Top Penny

Top Penny 4分前

Financials are NOT fake point blank period!!!

The GidDy uP Kid

The GidDy uP Kid 5分前

VIVS… https://schrts.co/NieenYHI

The GidDy uP Kid

The GidDy uP Kid 5分前

VIVS… https://schrts.co/NieenYHI

DrivenByPain

DrivenByPain 5分前

🤑SNTX🤑 Time Bomb $🤑$ Time Bomb https://www.youtube.com/watch?v=-nFVOukrl_A

The GidDy uP Kid

The GidDy uP Kid 5分前

VIVS… https://schrts.co/NieenYHI

DavidW2

DavidW2 6分前

Anyone lives at London? can visit NWBO facility? or lives at Maryland, can visit NWBO office? to find out what is current status? This company keep silent too long and keeps dilute the shares without telling investors for any reason. I think this is very unfair to investors!

Talisman33

Talisman33 6分前

The retailer (betterhealth) they use to sell Lunar has been listing it at 40% off for at least two months now, right? How is that better than trying to sell it on the largest national retailer platform Amazon at full price with subscription discount? Sure Lunar is not their core product, but it li

ge11

Trump will make the calls from here on out. Mark Smith has little to say where NioCorp will go from here. I wish Trump had control of what these people are compensated for what they get done for their shareholders. Hopefully they make it right with their long time shareholders someday.

TieetCoolee

TieetCoolee 6分前

It didn't work 🫩😝
$FMCC~ $FNMA~ ZOMBIE STOCKS RULE!

Goats'nCrows

Goats'nCrows 7分前

I'm an 85 IQ guy who works with hydraulic fluid and axle grease, so you're going to have to help me out with what you mean.

My 150 IQ friends tell me the guy you're awarding laurels is a moron, however.

Sunnybank

Sunnybank 7分前

Yowzers-offense woke up. Thank goodness for Uncle Ben. Hope Fried comes back more consistently than Cole an Rodon. Grisham coming on. Wells and Volpe showing flashes. Defense shaky. As you say lots of parity. Dodgers definitely the cream of the crop. Phillies coming on strong. Braves doing a great Y

DrivenByPain

DrivenByPain 9分前

🤑SNTX🤑 Push It $🤑$ https://www.youtube.com/watch?v=Ps0MfBG5-Uo

goldfinger

goldfinger 9分前

When the clowns come on bashers know there days are numbered.

Aquahoya

Aquahoya 10分前

Will be interesting. Like I said, I got a message saying he will have something soon. But soon is relative. Could be next week or many many weeks from now. We all know they are looking for portfolio / partnership. Would be nice to get this over .0010 before it comes.

Doc logic

Doc logic 10分前

biotech_researcher,

Don’t worry about big pharma going down, there will be merger lifeboats for some of them. Even some of those market makers might get a life vest and the Carpathia can pick them up; ). Best wishes.

Top Penny

Top Penny 13分前

Bye bye shorty

https://investorshub.advfn.com/uimage/uploads/2025/8/12/sjgigmargin-calls-1024x576.jpg

along4zride

along4zride 14分前

How about some specifics . None is never offered. Why hasn’t (FNMA) been relisted when they have met the requirements for many months ?
Answer:
They haven’t and they won’t .Cancellation is in play .
Poster is all hat and no (FNMA) cattle.

Naught

Naught 14分前

Please ask Gemini if the receivership has ANY control over the PAC moving forward..

Doc logic

Doc logic 14分前

Goat’snCrows,

I can imagine that he’s going to look great on the witness stand while the jury is lifting their glasses of grapefruit juice to toast him; ). Best wishes.

madras50

madras50 14分前

Last 2 press releases indicate this should be well above where it is. This one for real?

biotech_researcher

biotech_researcher 14分前

This is a disaster of epic proportions…

pinhigh

pinhigh 14分前

Your anticipated BS artie! You were undoubtedly one of the kings of Biel shorters. So sorry your revenue source is drying up! LOL Go Biel!

BTB Real Estate Investment (PK)

Natwest Markets

Natwest Mk. 23�

First Trust Active Globa...

Bank Polska Kasa Opieki (PK)

Agf American Growth Clas...

Barclays Bank Plc Autoca...

Sterling vs RWF

WisdomTree Commodity Sec...

BlackRock Institutional ...

FTSE Taiwan Ric Capped TWD

5.625% Nts 05/10/33

0.5% until 23apr2041

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。